+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type; Profiling Technology; Cancer Type; Application and Geography- Product Image
Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type; Profiling Technology; Cancer Type; Application and Geography- Product Image
Sale

Cancer Biomarkers Market to 2027 - Global Analysis and Forecasts By Biomarker Type; Profiling Technology; Cancer Type; Application and Geography

  • PDF Icon

    Report

  • 241 Pages
  • October 2019
  • Region: Global
  • The Insight Partners
  • ID: 4858416
UP TO OFF until Dec 31st 2024
Description Jump to:

The global cancer biomarkers market is expected to reach US$ 31,206.00 Mn in 2027 from US$ 12,175.69 in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027.

Driving factors such as growing cancer prevalence across the globe, new product launches and FDA approvals, and technological advancements are expected to boost the market over the years. However unfavorable regulatory and reimbursement scenario is likely to have a negative impact on the growth of the market in the coming years. Besides, the development opportunities in emerging countries are likely to have a positive effect on the growth of the market in the forecast years.

Cancer immunotherapies are rapidly replacing traditional treatment standards and expanding the therapeutic landscape for cancer patients. Researchers are focused on finding molecules in the blood that can signal the appearance of cancers. For the diagnosis of ovarian and prostate cancers, the cancer antigen (CA)125 and prostate-specific antigen (PSA) are used alongside other tests. Additionally, advancements in high-throughput omics technologies, including genomics, proteomics, transcriptomics, and metabolomics, has accelerated the pace of biomarker discovery.

The emerging markets like the Asia Pacific are creating better opportunities for significant market players to expand their business. This is a prime reason for market growth in the forecast period. Most of the major players focus on emerging countries such as India, China, and others owing to a large number of cancer patients and growing medical tourism in developing countries. Most of the emerging countries are preferred place for medical tourism. As per the Australian Institute of Health and Welfare, 140,000 new cases of cancer are diagnosed in 2018 and the low cost of surgeries, advanced technologies with less waiting time for procedures in the region is likely to boost the demand for cancer biomarkers.

In 2018, the breast cancer segment accounted for the largest market share in the global cancer biomarkers market by the cancer type segment. The biological features of the tumor used for estimating diagnosis and select suitable therapy for patients with breast cancer. HER2 is a growth factor receptor present on the surface of breast cells. Approximately 30% of breast cancer patients have tumors, which expresses a large amount of HER2. Various anti-cancer drugs are targeted for protein, making an accurate determination of the presence or absence of the protein in a tumor a vital step in calculating the proper treatment. At present, the cases of cancer are increasing across the globe.

The global cancer biomarkers market is segmented by biomarker type, profiling technology, cancer type, application, and end-user. On the basis of product, the market is segmented into antibodies, equipment, reagents, and kits. On the basis of cancer type, the market is segmented into breast cancer, lung cancer, prostate cancer, leukemia, bladder cancer, and other cancer types. Based on application, the market is segmented into diagnostics, research and development, prognostics, and other applications. On the basis of biomarker type, the market is segmented into genetic biomarkers, protein biomarkers and other cancer biomarkers. On the basis of profiling technology, the market is segmented into omics technologies, imaging technologies, immunoassays, cytogenetics, and bioinformatics.

Some of the important primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Cancer Association of South Africa (CANSA), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR),

Reasons to Buy:


  • Save and reduce time carrying out entrylevel research by identifying the growth, size, leading players and segments in the cancer biomarkers market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global cancer biomarkers market, thereby allowing players across the value chain to develop effective longterm strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize indepth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decisionmaking process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cancer Biomarkers Market - By Biomarker Type
1.3.2 Global Cancer Biomarkers Market - By Profiling Technology
1.3.3 Global Cancer biomarkers Market - By Cancer Type
1.3.4 Global Cancer biomarkers Market - By Application
1.3.5 Global Cancer biomarkers Market - By Geography
2. Global Cancer biomarkers Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Cancer biomarkers Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cancer Biomarkers Market - North America PEST Analysis
4.2.2 Cancer Biomarkers Market - Europe PEST Analysis
4.2.3 Cancer Biomarkers Market - Asia Pacific PEST Analysis
4.2.4 Cancer Biomarkers Market - Middle East & Africa PEST Analysis
4.2.5 Cancer Biomarkers Market - South and Central America PEST Analysis
5. Global Cancer Biomarkers Market - Key Industry Dynamics
5.1.1 Growing Cancer Prevalence Across The Globe
5.1.2 New Product Launches & FDA Approvals
5.1.3 Technological Advancements
5.2 Key Market Restraints
5.2.1 Unfavourable Regulatory and Reimbursement Scenario
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Inclination Towards Personalized Medicine
5.5 Impact Analysis
6. Cancer biomarkers Market - Global Analysis
6.1 Global Cancer biomarkers Market Revenue Forecasts And Analysis
6.2 Global Cancer biomarkers Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players
7. Cancer biomarkers Market Revenue And Forecasts To 2027 - Biomarker Type
7.1 Overview
7.2 Global Cancer Biomarkers Market Share by Biomarker Type 2018 & 2027 (%)
7.3 Genetic Biomarkers
7.3.1 Overview
7.3.2 Genetic Biomarkers Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Protein Biomarkers
7.4.1 Overview
7.4.2 Protein Biomarkers Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Other Cancer Biomarkers
7.5.1 Overview
7.5.2 Other Cancer Biomarkers Market Revenue and Forecast to 2027 (US$ Mn)
8. Cancer Biomarkers Market Analysis And Forecasts To 2027 - Profiling Technology
8.1 Overview
8.2 Global Cancer Biomarkers Market Share by Profiling Technology 2018 & 2027 (%)
8.3 Omics Technologies
8.3.1 Overview
8.3.2 Omics Technologies Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Imaging Technologies
8.4.1 Overview
8.4.2 Imaging Technologies Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3 Ultrasound
8.4.3.1 Overview
8.4.3.2 Ultrasound Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4 Computed Tomography (CT)
8.4.4.1 Overview
8.4.4.2 Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
8.4.5 Magnetic Resonance Imaging (MRI)
8.4.5.1 Overview
8.4.5.2 Global Magnetic Resonance Imaging (MRI) Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.6 Positron Emission Tomography (PET) Market
8.4.6.1 Overview
8.4.6.2 Global Positron Emission Tomography (PET) Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Immunoassays
8.5.1.1 Overview
8.5.1.2 Immunoassays Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Cytogenetics
8.6.1 Overview
8.6.2 Cytogenetics Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Bioinformatics
8.7.1 Overview
8.7.2 Bioinformatics Market Revenue and Forecast to 2027 (US$ Mn)
9. Global Cancer biomarkers Market Revenue And Forecasts To 2027 - by Cancer Type
9.1 Overview
9.2 Global Cancer Biomarkers Market, By Cancer Type 2018 & 2027 (%)
9.3 Breast Cancer Market
9.3.1 Overview
9.3.2 Global Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Lung Cancer Market
9.4.1 Overview
9.4.2 Global Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Prostate Cancer Market
9.5.1 Overview
9.5.2 Global Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Leukemia Market
9.6.1 Overview
9.6.2 Global Leukemia Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Bladder Cancer Market
9.7.1 Overview
9.7.2 Global Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.8 Other Cancer Market
9.8.1 Overview
9.8.2 Global Other Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
10. Global Cancer biomarkers Market Revenue And Forecasts To 2027 - by Application
10.1 Overview
10.2 Global Cancer Biomarkers Market, By Application 2018 & 2027 (%)
10.3 Diagnostics Market
10.3.1 Overview
10.3.2 Global Diagnostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Research and Development Market
10.4.1 Overview
10.4.2 Global Research and Development Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Prognostics Market
10.5.1 Overview
10.5.2 Global Prognostics Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
10.6 Others Market
10.6.1 Overview
10.6.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
11. Cancer Biomarkers Market Revenue and Forecasts to 2027 - Geographical Analysis
11.1 North America Cancer Biomarkers Market Revenue And Forecasts To 2027
11.1.1 North America Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.1.3 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.1.3.1 North America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.4 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.1.5 North America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.6 North America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.1.7 US Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.1 US Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.1.7.3 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.1.7.3.1 US Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.7.4 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.1.7.5 US Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.8 Canada Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 Canada Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.1.8.3 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.1.8.3.1 Canada Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.4 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.1.8.5 Canada Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.9 Mexico Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.1 Mexico Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.2 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.1.9.3 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.1.9.3.1 Mexico Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.9.4 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.1.9.5 Mexico Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2 Europe Cancer Biomarkers Market Revenue And Forecasts To 2027
11.2.1 Europe Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.2 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.3 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.3.1 Europe Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.5 Europe Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.6 Europe Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.2.7 UK Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.1 UK Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.2 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.7.3 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.7.3.1 UK Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.7.4 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.7.5 UK Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.8 Germany Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.1 Germany Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.8.3 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.8.3.1 Germany Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.8.4 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.8.5 Germany Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.9 France Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.1 France Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.9.3 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.9.3.1 France Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.4 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.9.5 France Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.10 Italy Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.1 Italy Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.10.3 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.10.3.1 Italy Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.10.4 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.10.5 Italy Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.11 Spain Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.1 Spain Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.2.11.3 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.2.11.3.1 Spain Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.4 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.2.11.5 Spain Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts To 2027
11.4 Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.1 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.2 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.2.1 Asia Pacific Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.3 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.4 Asia Pacific Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.5 Asia Pacific Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.4.6 Japan Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.6.1 Japan Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.6.2 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.6.3 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.6.3.1 Japan Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.6.4 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.6.5 Japan Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.7 China Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.1 China Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.2 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.7.3 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.7.3.1 China Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.4 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.7.5 China Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.8 India Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.1 India Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.2 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.8.3 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.8.3.1 India Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.8.4 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.8.5 India Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.9 South Korea Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.1 South Korea Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.2 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.9.3 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.9.3.1 South Korea Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.4 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.9.5 South Korea Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.10 Australia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.10.1 Australia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.10.2 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.4.10.3 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.4.10.3.1 Australia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.10.4 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.4.10.5 Australia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5 Middle East & Africa Cancer biomarkers Market Revenue And Forecasts To 2027
11.5.1 Middle East & Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.2 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.5.3 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.5.3.1 Middle East & Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.4 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.5.5 Middle East & Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.6 Middle East & Africa Cancer biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.5.7 UAE Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.7.1 UAE Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.5.9 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.5.9.1 UAE Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.10 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.5.11 UAE Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.12 Saudi Arabia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.12.1 Saudi Arabia Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.13 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.5.14 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.5.14.1 Saudi Arabia Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.15 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.5.16 Saudi Arabia Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.17 South Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.17.1 South Africa Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.18 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.5.19 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.5.19.1 South Africa Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.20 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.5.21 South Africa Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.6 South And Central America Cancer Biomarkers Market Revenue And Forecasts To 2027
11.6.1 South and Central America Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.2 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.6.3 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.6.3.1 South and Central America Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.6.4 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.6.5 South and Central America Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.6.6 South and Central America Cancer Biomarkers Market Revenue and Forecasts to 2027, By Country (%)
11.6.7 Argentina Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.7.1 Argentina Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.8 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.6.9 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.6.9.1 Argentina Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.6.10 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.6.11 Argentina Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.6.12 Brazil Cancer Biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.12.1 Brazil Cancer biomarkers Market Revenue and Forecasts to 2027 (US$ Mn)
11.6.13 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Biomarker Type (US$ Mn)
11.6.14 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Profiling Technology (US$ Mn)
11.6.14.1 Brazil Imaging Technologies Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.6.15 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Cancer Type (US$ Mn)
11.6.16 Brazil Cancer Biomarkers Market Revenue And Forecasts to 2027, By Application (US$ Mn)
12. Cancer Biomarkers Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies done by the companies in the Market, 2018 (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Cancer biomarkers Market-Key Company Profiles
13.1 Bio-Rad Laboratories, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Information
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Information
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.5 Qiagen N.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.7 Illumina, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Myriad Genetics, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Hologic Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Quest Diagnostics Incorporated
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 BioMérieux SA
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Financial Information
13.11.4 Product Portfolio
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Creative Diagnostics
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Financial Overview
13.12.4 Product Portfolio
13.12.5 SWOT ANALYSIS
13.12.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

Companies Mentioned

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Hologic Inc.
  • Quest Diagnostics Incorporated
  • bioMérieux SA
  • Creative Diagnostics

Related Topics

Related Reports

Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), Enduser, and Region - Forecast to 2029 - Product Image

Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), Enduser, and Region - Forecast to 2029

  • Report
  • 339 Pages
  • Global
From
Cancer Biomarkers Market Report by Profiling Technology, Biomolecule, Cancer Type, Application, End User, and Region 2024-2032 - Product Image

Cancer Biomarkers Market Report by Profiling Technology, Biomolecule, Cancer Type, Application, End User, and Region 2024-2032

  • Report
  • 150 Pages
  • Global
From
Cancer Biomarker Global Market Report 2024 - Product Image

Cancer Biomarker Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Oncology Biomarkers Global Market Report 2024 - Product Image

Oncology Biomarkers Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Cancer Biomarkers - Global Strategic Business Report - Product Image

Cancer Biomarkers - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.